COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination
Authors
Keywords
-
Journal
Brain Sciences
Volume 10, Issue 6, Pages 345
Publisher
MDPI AG
Online
2020-06-04
DOI
10.3390/brainsci10060345
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The neuroinvasive potential of SARS‐CoV2 may be at least partially responsible for the respiratory failure of COVID‐19 patients
- (2020) Yan‐Chao Li et al. JOURNAL OF MEDICAL VIROLOGY
- Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
- (2020) Yushun Wan et al. JOURNAL OF VIROLOGY
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
- (2020) Xiao-Wei Xu et al. BMJ-British Medical Journal
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms
- (2020) Abdul Mannan Baig et al. ACS Chemical Neuroscience
- SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients
- (2020) Yongbo Huang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19
- (2020) Alfred H.J. Kim et al. ANNALS OF INTERNAL MEDICINE
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients
- (2020) Xiaohua Chen et al. CLINICAL INFECTIOUS DISEASES
- Neurological manifestations in COVID‐19 caused by SARS‐CoV‐2
- (2020) Abdul Mannan Baig CNS Neuroscience & Therapeutics
- Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
- (2020) Melissa Bersanelli Immunotherapy
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A first case of meningitis/encephalitis associated with SARS-Coronavirus-2
- (2020) Takeshi Moriguchi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
- (2020) Fan Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Response to “Comments on 'Zhang et al: Clinical trial analysis of 2019‐nCoV therapy registered in China'”
- (2020) Qi Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Neurological manifestations associated with COVID-19: a review and a call for action
- (2020) Matilde Leonardi et al. JOURNAL OF NEUROLOGY
- Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2
- (2020) M. D. Willis et al. JOURNAL OF NEUROLOGY
- Neurologists and COVID-19
- (2020) Renée A. Shellhaas NEUROLOGY
- Guillain–Barré Syndrome Associated with SARS-CoV-2
- (2020) Gianpaolo Toscano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- (2020) Yan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features
- (2020) Neo Poyiadji et al. RADIOLOGY
- Sars-Cov-2: Underestimated damage to nervous system
- (2020) Lingyan Zhou et al. Travel Medicine and Infectious Disease
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
- (2020) Ling Mao et al. JAMA Neurology
- The COVID-19 pandemic and the use of MS disease-modifying therapies
- (2020) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- Coronavirus disease 2019 (COVID-19): a clinical update
- (2020) Min Zhou et al. Frontiers of Medicine
- Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
- (2020) Amr H. Sawalha et al. CLINICAL IMMUNOLOGY
- Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review
- (2020) V. Montalvan et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- An Italian programme for COVID-19 infection in multiple sclerosis
- (2020) Maria Pia Sormani LANCET NEUROLOGY
- COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
- (2020) Giovanni Novi et al. Multiple Sclerosis and Related Disorders
- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- Human coronavirus circulation in the United States 2014–2017
- (2018) Marie E. Killerby et al. JOURNAL OF CLINICAL VIROLOGY
- Axonal Transport Enables Neuron-to-Neuron propagation of HCoV-OC43
- (2018) Mathieu Dubé et al. JOURNAL OF VIROLOGY
- Cognition During and After Multiple Sclerosis Relapse as Assessed With the Brief International Cognitive Assessment for Multiple Sclerosis
- (2018) Natasa Giedraitiene et al. Scientific Reports
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- A Systematic Assessment of Prevalence, Incidence and Regional Distribution of Multiple Sclerosis in Bavaria From 2006 to 2015
- (2018) Tanja Daltrozzo et al. Frontiers in Neurology
- Neurological Complications during Treatment of Middle East Respiratory Syndrome
- (2017) Jee-Eun Kim et al. Journal of Clinical Neurology
- Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities
- (2017) Alexios-Fotios A. Mentis et al. MOLECULAR NEUROBIOLOGY
- Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality
- (2017) Anja Thormann et al. NEUROLOGY
- Severe cytokine release syndrome in a patient receiving PD-1-directed therapy
- (2017) Seth J. Rotz et al. PEDIATRIC BLOOD & CANCER
- Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
- (2017) Chipman RG Stroud et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Multiple sclerosis prevalence in the United States commercially insured population
- (2016) Piyameth Dilokthornsakul et al. NEUROLOGY
- Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
- (2016) Shuo Su et al. TRENDS IN MICROBIOLOGY
- A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
- (2015) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
- (2015) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- Characterizing cognitive function during relapse in multiple sclerosis
- (2014) Ralph HB Benedict et al. Multiple Sclerosis Journal
- Comorbidity increases the risk of hospitalizations in multiple sclerosis
- (2014) R. A. Marrie et al. NEUROLOGY
- Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database
- (2013) I. S. Mackenzie et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication
- (2012) Yan-Chao Li et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Olfaction in Parkinson's disease and related disorders
- (2011) Richard L. Doty NEUROBIOLOGY OF DISEASE
- The rising prevalence and changing age distribution of multiple sclerosis in Manitoba
- (2010) R. A. Marrie et al. NEUROLOGY
- Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2
- (2008) J. Netland et al. JOURNAL OF VIROLOGY
- Imaging of Acute Disseminated Encephalomyelitis
- (2008) Andrea Rossi NEUROIMAGING CLINICS OF NORTH AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started